Last reviewed · How we verify

NCT07468149

REHABOTICS: Physiotherapy for Hand Spasticity After Stroke Using Robotics and AR Serious Games

Completed NA Last updated 12 March 2026
What this trial tests

NA trial testing Rehabotics Physiotherapy in Stroke in 80 participants. Completed in 31 December 2025.

Timeline
1 January 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorPantelis Syringas
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment80
Start date1 January 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Pantelis Syringas

Who can join

Adults 30 to 85, any sex, with Stroke or Upper Extremity Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rehabotics is a comprehensive rehabilitation system designed to deliver individualized upper-limb therapy for patients with motor impairments, particularly after stroke. Its core components include an exoskeletal robotic aid for assisted hand training and an interactive augmented reality platform for rehabilitation exercises and functional task practice. The system supports both treatment and assessment by enabling the monitoring of motor performance and patient progress through quantitative data. The overall aim of Rehabotics is to enhance the quality, intensity, and personalization of hand rehabilitation in clinical settings, with the potential to support remote care applications in the future.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Rehabotics Physiotherapy

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Pantelis Syringas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07468149.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing